Export 20 results:
Author Title Type [ Year
Filters: Author is Belshe, Robert B [Clear All Filters]
“Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women”, J Infect Dis, vol. 227, no. 4, pp. 522-527, 2023.
, “Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.”, PLoS One, vol. 14, no. 4, p. e0214467, 2019.
, “Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.”, J Virol, vol. 91, no. 23, 2017.
, “Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.”, Vaccine, vol. 34, no. 4, pp. 547-554, 2016.
, “Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.”, J Infect Dis, vol. 214, no. 7, pp. 1020-9, 2016.
, “Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.”, Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
, “Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”, Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
, “Correlate of immune protection against HSV-1 genital disease in vaccinated women.”, J Infect Dis, vol. 209, no. 6, pp. 828-36, 2014.
, “HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).”, South Med J, vol. 107, no. 2, pp. 79-84, 2014.
, “Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.”, JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
, , “Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.”, Clin Infect Dis, vol. 56, no. 3, pp. 344-51, 2013.
, “Efficacy results of a trial of a herpes simplex vaccine.”, N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
, “Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”, J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
, “Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.”, J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
, “Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.”, Vaccine, vol. 28, no. 38, pp. 6367-73, 2010.
, “Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.”, Vaccine, vol. 25, no. 37-38, pp. 6755-63, 2007.
, “Dose-dependent neutralizing-antibody responses to vaccinia.”, J Infect Dis, vol. 189, no. 3, pp. 493-7, 2004.
, “Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.”, J Infect Dis, vol. 190, no. 7, pp. 1286-94, 2004.
, “Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.”, J Infect Dis, vol. 187, no. 8, pp. 1319-22, 2003.
,